These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Severe immune hemolytic anemia associated with prophylactic use of cefotetan in obstetric and gynecologic procedures.
    Author: Garratty G, Leger RM, Arndt PA.
    Journal: Am J Obstet Gynecol; 1999 Jul; 181(1):103-4. PubMed ID: 10411803.
    Abstract:
    Second- and third-generation cephalosporins, especially cefotetan, are increasingly associated with severe, sometimes fatal immune hemolytic anemia. We noticed that 10 of our 35 cases of cefotetan-induced hemolytic anemias were in patients who had received cefotetan prophylactically for obstetric and gynecologic procedures. Eight of these cases of severe immune hemolytic anemia are described.
    [Abstract] [Full Text] [Related] [New Search]